By Doug Macron
Alnylam Pharmaceuticals this week fired back at partner Tekmira Pharmaceuticals in the companies' ongoing legal dispute by claiming it misappropriated trade secrets to bolster its own drug-delivery technology-development efforts.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now. Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.
In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.
Adam Rutherford discusses genetic genealogy at the Guardian.
Portions of the US 21st Century Cures Act are raising some safety concerns.